Diego Cadavid - SVP Clinical Development, Fulcrum Therapeutics, Inc

As of July 2, 2020


Diego Cadavid Net Worth

  • Net worth is estimated to be at least $1.92M
  • Owns at least 65,714 units of Fulcrum Therapeutics, Inc stock
  • Sold an estimated value of $205.75K in the last year at Fulcrum Therapeutics, Inc

Diego Cadavid Trading

  • Largest purchase of shares was 1,860 units , worth over $8.98K on May 12, 2020
  • Largest sale of shares was 2,143 units , worth over $37.25K on March 2, 2020
  • In total has made about 11 transactions over a year
  • Usually trades in June, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Diego Cadavid Mailing Address

  • Mailing address is C/o Fulcrum Therapeutics, Inc. 26 Landsdowne Street Cambridge MA 02139 MA

Fulcrum Therapeutics, Inc Insider Trading

  • The most recent transaction was 51,785 units sold on August 12, 2021 by Christopher Moxham worth over $911.42K
  • In the last 2 years, insiders at Fulcrum Therapeutics, Inc sold an estimated value of $3.86M and bought an estimated value of $10.74M
  • The most active traders are Robert J Gould, See Remarks,  Diego Cadavid, SVP Clinical Development,  and Owen B Wallace, Chief Scientific Officer
  • Insider trading is most common in June, with the busiest year in 2020

Fulcrum Therapeutics, Inc. Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1